Should I buy or sell Check-Cap stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Check-Cap in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CHEK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CHEK, but not buy additional shares or sell existing shares. View CHEK analyst ratings or view top-rated stocks .

How have CHEK shares performed in 2024?

Check-Cap's stock was trading at $2.08 at the start of the year. Since then, CHEK stock has increased by 7.7% and is now trading at $2.24. View the best growth stocks for 2024 here .

Are investors shorting Check-Cap?

Check-Cap saw a increase in short interest in March. As of March 31st, there was short interest totaling 600,000 shares, an increase of 1,377.8% from the March 15th total of 40,600 shares. Based on an average daily volume of 249,300 shares, the short-interest ratio is presently 2.4 days. Approximately 13.5% of the shares of the stock are short sold. View Check-Cap's Short Interest .

When is Check-Cap's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our CHEK earnings forecast .

How were Check-Cap's earnings last quarter?

Check-Cap Ltd. (NASDAQ:CHEK) released its quarterly earnings results on Monday, November, 27th. The medical research company reported ($0.44) earnings per share for the quarter, topping analysts' consensus estimates of ($0.83) by $0.39.

When did Check-Cap's stock split?

Check-Cap shares reverse split on the morning of Friday, November 25th 2022. The 1-20 reverse split was announced on Friday, November 25th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, November 25th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Check-Cap own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Check-Cap investors own include Alibaba Group (BABA) , Navios Maritime Partners (NMM) , New Residential Investment (NRZ) , Heat Biologics (HTBX) , Sorrento Therapeutics (SRNE) , TherapeuticsMD (TXMD) , Acasti Pharma (ACST) , Avinger (AVGR) , Biocept (BIOC) and Purple Biotech (KTOV) .

When did Check-Cap IPO?

Check-Cap (CHEK) raised $13 million in an initial public offering on Thursday, February 19th 2015. The company issued 1,200,000 shares at $10.00-$12.00 per share. Chardan Capital Markets and Maxim Group acted as the underwriters for the IPO and Feltl and Company was co-manager.

How do I buy shares of Check-Cap?

Shares of CHEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:CHEK

Check-Cap (CHEK) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free CHEK Stock Alerts

$2.24

+0.06 (+2.75%)

(As of 04/16/2024 ET)

Compare

Today's Range: $2.17
▼
$2.36
50-Day Range: $1.87
▼
$3.11
52-Week Range: $1.27
▼
$4.63

Volume: 13,405 shs
Average Volume: 225,567 shs
Market Capitalization: $13.10 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Check-Cap alerts:

Check-Cap MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Bearish
13.48% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.49
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($2.05) to ($0.68) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.23 out of 5 stars

Medical Sector

910th out of 930 stocks

X - Ray Apparatus & Tubes Industry

4th out of 4 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Check-Cap.

2.0

Short Interest

Percentage of Shares Shorted
13.48% of the float of Check-Cap has been sold short.
Short Interest Ratio / Days to Cover
Check-Cap has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Check-Cap has recently increased by 1,377.83%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Check-Cap does not currently pay a dividend.
Dividend Growth
Check-Cap does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CHEK.

2.5

News and Social Media Coverage

News Sentiment
Check-Cap has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Check-Cap this week, compared to 1 article on an average week.
Search Interest
3 people have searched for CHEK on MarketBeat in the last 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Check-Cap insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.48% of the stock of Check-Cap is held by insiders.
Percentage Held by Institutions
Only 1.07% of the stock of Check-Cap is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Check-Cap are expected to grow in the coming year, from ($2.05) to ($0.68) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Check-Cap is -0.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Check-Cap is -0.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Check-Cap has a P/B Ratio of 0.26. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Check-Cap Stock (NASDAQ:CHEK)

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

CHEK Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CHEK Stock News Headlines

April 15, 2024 | americanbankingnews.com

Check-Cap (NASDAQ:CHEK) Coverage Initiated at StockNews.com

April 7, 2024 | americanbankingnews.com

Check-Cap (NASDAQ:CHEK) Receives New Coverage from Analysts at StockNews.com

April 16, 2024 | Manward Press (Ad)

Can't believe it's happening again

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

March 26, 2024 | msn.com

AI-Powered Real Estate Marketplace Nobul AI To Acquire Medical-Diagnostics Company Check-Cap

March 26, 2024 | investorplace.com

Why Is Check-Cap (CHEK) Stock Up 44% Today?

March 25, 2024 | prnewswire.com

Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement

March 19, 2024 | msn.com

What the Chargers can do with their cap space after roster moves

March 8, 2024 | msn.com

How much cap space do the Seahawks have after trio of Tuesday cuts?

April 16, 2024 | Manward Press (Ad)

Can't believe it's happening again

February 24, 2024 | jaguarswire.usatoday.com

Larger than expected salary cap means more space for Jaguars

February 23, 2024 | msn.com

Bengals emerge big winners with updated cap space after 2024 cap reveal

February 10, 2024 | investing.com

Check Cap Ltd (CHEK)

December 22, 2023 | finance.yahoo.com

SYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTD

December 14, 2023 | finance.yahoo.com

Check-Cap Board of Directors Issues Letter to Shareholders

December 8, 2023 | finance.yahoo.com

CITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEES

December 7, 2023 | finance.yahoo.com

Leading Independent Proxy Advisory Firm ISS Recommends Check-Cap Shareholders Vote FOR the Keystone Dental Business Combination Agreement

December 5, 2023 | finance.yahoo.com

CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER AND FOR THE SYMETRYX BOARD OF DIRECTORS NOMINEES

November 29, 2023 | benzinga.com

Check-Cap Stock (NASDAQ:CHEK) Earnings Dates and Earning Calls

November 28, 2023 | benzinga.com

Check-Cap Stock (NASDAQ:CHEK) Dividends: History, Yield and Dates

November 27, 2023 | benzinga.com

Check-Cap: Q3 Earnings Insights

November 27, 2023 | msn.com

Check-Cap GAAP EPS of -$0.44

November 27, 2023 | markets.businessinsider.com

Check-Cap Posts Narrower Loss In Q3 - Quick Facts

November 27, 2023 | finance.yahoo.com

Check-Cap Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

November 7, 2023 | morningstar.com

Check-Cap Ltd CHEK

October 31, 2023 | markets.businessinsider.com

Notice of Extraordinary General Meeting of Shareholders

October 27, 2023 | msn.com

Check out some of the caps you can get at a Bucks game this year

October 26, 2023 | bloomberg.com

Kazakhstan Aims to Cut Loan-Rate Cap

See More Headlines

Receive CHEK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Check-Cap and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/27/2023
Today: 4/16/2024
Next Earnings (Estimated): 5/09/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: X-ray apparatus & tubes
Sub-Industry: N/A
Current Symbol: NASDAQ:CHEK
CUSIP: N/A
CIK: 1610590
Web: www.check-cap.com
Phone: 972546706451
Fax: 972-4821-1267
Employees: 85
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($3.02)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-19,110,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -47.85%
Return on Assets: -43.50%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 17.60
Quick Ratio: 17.60

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $8.57 per share
Price / Book: 0.25

Miscellaneous

Outstanding Shares: 5,850,000
Free Float: 5,822,000
Market Cap: $12.75 million
Optionable: Not Optionable
Beta: 0.27

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Mr. Alex Ovadia (Age 62)
CEO & Director
Comp: $409.35k
Dr. Yoav Kimchy Ph.D. (Age 63)
Founder & Interim CTO
Comp: $362.65k
Mr. Joshua Belkar (Age 55)
Vice President of Operations
Comp: $269.57k
Ms. Mira Rosenzweig (Age 52)
Executive Officer
Comp: $287.99k
Ms. Iris Even-Tov
Interim Chief Financial Officer
Ms. Noa Reshef M.B.A.
Director of Human Resources

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

CHEK Stock Analysis - Frequently Asked Questions

Should I buy or sell Check-Cap stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Check-Cap in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CHEK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CHEK, but not buy additional shares or sell existing shares.
View CHEK analyst ratings or view top-rated stocks.
How have CHEK shares performed in 2024?: Check-Cap's stock was trading at $2.08 at the start of the year. Since then, CHEK stock has increased by 7.7% and is now trading at $2.24.
View the best growth stocks for 2024 here.
Are investors shorting Check-Cap?: Check-Cap saw a increase in short interest in March. As of March 31st, there was short interest totaling 600,000 shares, an increase of 1,377.8% from the March 15th total of 40,600 shares. Based on an average daily volume of 249,300 shares, the short-interest ratio is presently 2.4 days. Approximately 13.5% of the shares of the stock are short sold.
View Check-Cap's Short Interest.
When is Check-Cap's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our CHEK earnings forecast.
How were Check-Cap's earnings last quarter?: Check-Cap Ltd. (NASDAQ:CHEK) released its quarterly earnings results on Monday, November, 27th. The medical research company reported ($0.44) earnings per share for the quarter, topping analysts' consensus estimates of ($0.83) by $0.39.

When did Check-Cap's stock split?: Check-Cap shares reverse split on the morning of Friday, November 25th 2022. The 1-20 reverse split was announced on Friday, November 25th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, November 25th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.
What other stocks do shareholders of Check-Cap own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Check-Cap investors own include Alibaba Group (BABA), Navios Maritime Partners (NMM), New Residential Investment (NRZ), Heat Biologics (HTBX), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Acasti Pharma (ACST), Avinger (AVGR), Biocept (BIOC) and Purple Biotech (KTOV).
When did Check-Cap IPO?: Check-Cap (CHEK) raised $13 million in an initial public offering on Thursday, February 19th 2015. The company issued 1,200,000 shares at $10.00-$12.00 per share. Chardan Capital Markets and Maxim Group acted as the underwriters for the IPO and Feltl and Company was co-manager.
How do I buy shares of Check-Cap?: Shares of CHEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CHEK) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial